Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04630496 · ClinicalTrials.gov registry record · NA

Geriatric Thoracic Surgery Ambulation Challenge

A NA study of Surgery and Thoracic Diseases, sponsored by Dana-Farber Cancer Institute.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
2
Study locations

NCT04630496 is a NA study of Surgery and Thoracic Diseases that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 30 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04630496, a NA study of Surgery and Thoracic Diseases, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

This study is examining collecting data on steps walked (ambulation) per day by thoracic surgery patients over the age of 65 years-old before surgery. The name(s) of the study device involved in this study is: * Fitbit inspire

Interventions

  • BEHAVIORAL Fitbit

Study Locations (2)

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Dana-Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-08-25
Est. Completion 2026-01-01
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT04630496

The ClinicalTrials.gov registry entry for NCT04630496 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Fitbit is the first listed.

NCT04630496 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04630496 about?

NCT04630496 is a clinical study titled "Geriatric Thoracic Surgery Ambulation Challenge". This study is examining collecting data on steps walked (ambulation) per day by thoracic surgery patients over the age of 65 years-old before surgery. The name(s) of the study device involved in this study is: * Fitbit inspire

What is the current status of trial NCT04630496?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-08-25. Estimated completion is 2026-01-01.

What conditions does trial NCT04630496 study?

This clinical trial studies the following conditions: Surgery, Thoracic Diseases, Therapy, Exercise.

What interventions are being tested in trial NCT04630496?

The interventions under investigation include: Fitbit (BEHAVIORAL).

Who is sponsoring clinical trial NCT04630496?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04630496 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.